Parallax Volatility Advisers, L.P. Catalent, Inc. Put Options Transaction History

Parallax Volatility Advisers, L.P.

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 15, 2024	BUY	$42.56 - $59.82 $2.13 Million - $3 Million	50,100 New	50,100 $2.83 Million
Q2 2023 Aug 14, 2023	BUY	$31.86 - $67.26 $105,138 - $221,958	3,300 Added 16.18%	23,700 $1.03 Million
Q1 2023 May 15, 2023	BUY	$45.44 - $74.26 $926,976 - $1.51 Million	20,400 New	20,400 $1.34 Million
Q2 2020 Aug 14, 2020	SELL	$48.02 - $79.04 $1.2 Million - $1.98 Million	-25,000 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$36.95 - $62.95 $739,000 - $1.26 Million	-20,000 Reduced 44.44%	25,000 $1.3 Million
Q2 2019 Aug 14, 2019	BUY	$39.26 - $54.21 $294,450 - $406,575	7,500 Added 20.0%	45,000 $2.44 Million
Q1 2019 May 15, 2019	BUY	$29.84 - $43.92 $1.12 Million - $1.65 Million	37,500 New	37,500 $1.52 Million

118

37.8M

123K

432K

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.